Publications by authors named "T Ganten"

Claim this Profile
P
Prospective randomized controlled trial comparing a novel and dedicated device with conventional endoscopic techniques for the treatment of buried bumper syndrome (with video).
Andreas Wannhoff, Armin Küllmer, David Albers, Martin Fähndrich, Tom Ganten

Gastrointest Endosc· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors.
Andreas A Schnitzbauer, Natalie Filmann, René Adam, Philippe Bachellier, Wolf O Bechstein, Tom M Ganten

Ann Surg· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study.
Tom M Ganten, Rudolf E Stauber, Eckardt Schott, Peter Malfertheiner, Robert Buder

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
Ghassan K Abou-Alfa, Jean-Frederic Blanc, Steven Miles, Tom Ganten, Jörg Trojan

Oncologist· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Inter-Laboratory Variability on Model of End-Stage Liver Disease (MELD) Score Calculation.
Mohammed Al-Saeedi, Taha Yassein, Daniel Schultze, Arash Nickkholgh, Helge Bruns, Tom M Ganten

Ann Transplant· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis